About 900 reports

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the CNS Treatment and Therapy Market,...

  • Mental Health
  • Antipsychotic
  • World
  • Latin America
  • North America
  • Western Europe
  • Eastern Europe
  • Japan

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices,...

  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Drug Approval
  • Sports Participation Rate

Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Product Landscape, 2021 Summary Medical Devices sector report, “Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Spinal Cord Stimulators (SCS) pipeline products...

  • Clinical Trial
  • Therapy
  • United Kingdom
  • Direct Sales
  • Medical Devices Sales

The anaphylaxis treatment market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% during 2021–2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidence of anaphylaxis, and recent approvals of epinephrine. However,...

  • Therapy
  • World
  • APAC
  • Europe
  • Allergy Prevalence
  • Retail Revenue

The anaphylaxis treatment market in Europe is expected to grow from US$ 534.0 million in 2021 to US$ 987.2 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2021 to 2028. Anaphylaxis is a severe, life?threatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a...

  • Therapy
  • Europe
  • Retail Revenue
  • Allergy Prevalence

The global prostate health market is projected to reach USD 48.9 billion by 2026 from USD 31.8 billion in 2021, at a CAGR of 9.0% during the forecast period. The prostate gland (the prostate) is an organ of the male reproductive system. The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement...

  • Therapy
  • World
  • North America
  • Europe
  • United States
  • APAC
  • Overweight Prevalence
  • Health Expenditure

The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Growing prevalence of chronic diseases, increasing number of regulatory approvals, favourable reimbursement and government support, and technological advancements in injection pens tend...

  • Diabetes
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Diabetes Prevalence

The non-invasive aesthetic treatment market was valued at US$ 6,504.19 million in 2020 and is projected to reach US$ 18,656.54 million by 2028; it is expected to grow at a CAGR of 14.08% during 2020-2028. The market growth is attributed to the rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness...

  • Therapy
  • World
  • APAC
  • Europe
  • Cosmetic Procedures Performed
  • Drug Approval

The global neoantigens market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18.49% during 2020-2028. Cancer has emerged as a leading cause of death worldwide.According to the World Health Organization (WHO), cancer was the first leading cause of death...

  • Cancer
  • Therapy
  • World
  • APAC
  • Europe
  • Cancer Incidence
  • Cancer Mortality

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma...

  • Diabetes
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Northern Europe
  • Diabetes Prevalence
  • Health Provider Density

The global benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven owing to the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing...

  • Therapy
  • World
  • North America
  • Europe
  • United States
  • Japan
  • APAC
  • Overweight Prevalence
  • Drug Approval

The biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027. The increasing incidence of wounds and ulcers, and growing number of surgical procedures across the world fuel the market growth. Moreover, continuous innovations...

  • Therapy
  • World
  • North America
  • Europe
  • APAC
  • Diabetes Prevalence
  • Diabetes Incidence

The Europe addictions therapeutics market is expected to reach US$ 2,147.19 million by 2027 from US$ 1,410.85 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020 to 2027. The growth of the market is attributed to the rising approval of new drugs and launch of digital therapeutics to treat addiction, and increasing...

  • Therapy
  • Europe
  • Smoking Prevalence
  • Alcohol Excessive Use

The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies...

  • Therapy
  • Genitourinary System Disease
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Health Expenditure
  • Mortality Rate

The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various...

  • Chronic Disease
  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Chronic Disease Prevalence
  • Diabetes Prevalence

The addictions therapeutics market was valued at 6,691.01 million in 2019 and is projected to reach US$ 10,735.94 million by 2027; it is expected to grow at a CAGR of 6.2% from 2020 to 2027. Rising addiction among the general populace and increasing awareness campaigns are among the major factors fueling the growth of the market. Moreover,...

  • Therapy
  • World
  • APAC
  • Europe
  • Smoking Prevalence
  • Alcohol Excessive Use

The Netherton syndrome market was valued at US$ 19.57 million in 2019 and is projected to reach US$ 74.31 million by 2027; it is expected to grow at a CAGR of 20.3%during 2020–2027. The growth of the Netherton syndrome market is mainly attributed to factors such as the rising number of awareness campaigns, and increasing number of drug...

  • Therapy
  • Epidemiology
  • World
  • United States
  • APAC
  • Europe
  • France
  • Germany
  • United Kingdom
  • Spain
  • Japan
  • Italy
  • Drug Approval
  • Final Consumption Expenditures

The infertility treatment devices and equipment market was valued at US$ 1,050.00 million in 2019 and is projected to reach US$ 1,973.68 million by 2027; it is expected to grow at a CAGR of 8.4% from 2020 to 2027. The growth of the infertility treatment devices and equipment market is mainly attributed to the increasing incidence of...

  • Therapy
  • World
  • North America
  • Europe
  • APAC
  • Fertility Rate
  • Birth Rate

The Europe anti-viral therapies market is expected to reach US$ 21,122.66 million by 2027 from US$ 11,401.67 million in 2019; it is estimated to grow at a CAGR of 8.1% during 2020–2027. The market is growth is primarily attributed to the increasing R&D expenditures in pharmaceutical companies and rising government support for research...

  • Antiviral
  • Europe
  • Drug Approval
  • HIV AIDS Prevalence

The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Additionally,...

  • Therapy
  • Cancer
  • World
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Health Expenditure

The global anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The growth of the anti - viral therapies market is mainly attributed to the increasing R&D expenditures by pharmaceutical companies, and rising government...

  • Therapy
  • APAC
  • World
  • Europe
  • Africa
  • Middle East
  • Drug Approval
  • Health Expenditure

The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...

  • Chronic Disease
  • Pharmaceutical
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Drug Approval

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 17 molecules. Out...

  • Therapy
  • Pharmaceutical
  • Diabetes
  • Dementia
  • Digestive System Disorder
  • World
  • Northern Europe
  • Diabetes Prevalence
  • Food Consumption

Abstract: - Global Hypercalcemia Treatment Market to Reach $19.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hypercalcemia Treatment estimated at US$10.7 Billion in the year 2020, is projected to reach a revised size of US$19.9 Billion by 2027, growing at a CAGR of 9.3% over the analysis period...

  • Hormone
  • Generic Drug
  • World
  • China
  • Europe
  • United States

The cell therapy market will show rapid growth due to the increasing prevalence of chronic conditions, rising adoption of regenerative medicine and rise in the number of clinical studies pertaining to the development of cellular therapies. Chronic diseases and conditions are on the rise worldwide. According to the World Health Organization,...

  • Cell Therapy
  • Therapy
  • Pharmaceutical
  • World
  • Europe
  • APAC
  • South America
  • Africa
  • North America
  • Cancer Incidence
  • Chronic Disease Prevalence

The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4billion in 2021, at a CAGR of 31.4%. Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in...

  • Therapy
  • World
  • United States
  • North America
  • Europe
  • Health Expenditure
  • Chronic Disease Prevalence

The Male Infertility Market is expected to register a CAGR of 7.5% during the forecast period. This is attributing to the increasing incidence of infertility, high adoption of assisted reproductive technology (ART), technological advancement. According to the National Institute of Health (NIH), a report published in 2019, said that 8% to 10%...

  • Genitourinary System Disease
  • Urology
  • Therapy
  • Specialty Hospital
  • Diagnostics
  • Sandstone
  • APAC
  • Europe
  • Smoking Prevalence
  • Fertility Rate

Major players in the neutropenia biologic drug treatment market are Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, CVS Health Corp, Novartis, Spectrum Pharmaceuticals, and Partner Therapeutics. The global neutropenia biologic drug treatment market is expected to grow from $11.55 billion in 2020 to $12.19...

  • Biopharmaceutical
  • Therapy
  • World
  • France
  • APAC
  • Cancer Incidence
  • Cancer Mortality

The growing prevalence of several types of cancers in cats and dogs, as well as an increase in R&D initiatives regarding cancer management in animals, is contributing to the growth of the market. According to the Veterinary Cancer Society, cancer was the leading cause of death in 47% of dogs, especially those that are over the age of 10, and...

  • Cancer
  • Therapy
  • Veterinary Healthcare
  • APAC
  • Europe
  • Africa
  • South America
  • Drug Approval
  • Cancer Incidence

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021 Summary According to the recently published report ’Lysosomal Alpha Glucosidase - Drugs in Development, 2021’; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or...

  • Neurological Disorder
  • Therapy
  • World
  • Belgium
  • Number Of R&D Personnel
  • Pharmaceutical Exports